This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

An interactive tool for UK healthcare professionals to determine the recommended starting and target dose of Kerendia® (finerenone) in adults with symptomatic chronic heart failure (LVEF ≥ 40%) or Chronic Kidney Disease associated with type 2 diabetes, based on the latest UK Summary of Product Characteristics.

Loading ...

Abbreviations

DKD, diabetic kidney disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; LVEF, left ventricular ejection fraction; mmol/L and mEq/L, Units of measurement for serum potassium. For potassium, mmol/L and mEq/L are numerically equivalent; SmPC, Summary of Product Characteristics - the official prescribing information document for medicines in the UK.

PP-KER-GB-1035   |   July 2026